enzalutamide

This medicine is used in adult men to treat prostate cancer that does not respond to hormonal therapy or surgical treatment, has spread to other parts of the body, or in men in whom there is a rapid increase in PSA levels after surgery or radiation, and the cancer has not spread to other organs.

Form: capsules, soft gelatin

ATC: L02BB04

Manufacturer: Accord Healthcare B.V.

The medicine is intended for adult men with prostate cancer. It is used when the disease does not respond to hormonal or surgical therapy, when the cancer has spread to other parts of the body, or when there is a rapid increase in PSA levels following prostatectomy or radiation therapy.

Form: tablets, film-coated

ATC: L02BB04

Manufacturer: Lek Pharmaceuticals d.d.

This medicine is intended for adult men with prostate cancer. It is used when the disease does not respond to hormonal therapy or surgical treatment, when the cancer has spread to other parts of the body, or when there is a rapid increase in PSA levels following prostatectomy or radiation therapy.

Form: tablets, film-coated

ATC: L02BB04

Manufacturer: Lek Pharmaceuticals d.d.

The medicine is intended for adult men with prostate cancer for whom hormonal or surgical treatment is no longer effective, or in cases where the cancer has spread to other parts of the body.

Form: tablets, film-coated

ATC: L02BB04

Manufacturer: Lek Pharmaceuticals d.d. PharOS Mt Ltd

This medicine is used in adult men to treat prostate cancer that does not respond to hormonal therapy or surgical treatment, or that has spread to other parts of the body. It is also used in men after prostate removal or radiation therapy, in whom there has been a rapid increase in PSA levels.

Form: tablets, film-coated

ATC: L02BB04

Manufacturer: Lek Pharmaceuticals d.d. PharOS Mt Ltd

This medicine is used in adult men to treat prostate cancer in situations where the disease does not respond to hormonal or surgical therapy, when the cancer has spread to other parts of the body, or in men after prostate removal/radiation who experience a rapid increase in PSA levels.

Form: tablets, film-coated

ATC: L02BB04

Manufacturer: Lek Pharmaceuticals d.d. PharOS Mt Ltd Pharos Pharmaceutical Oriented Services Ltd.

This medicine is intended for adult men with prostate cancer. It is used when the disease does not respond to hormonal or surgical therapy, when the cancer has spread to other parts of the body, or in men after prostate removal or radiation therapy who experience a rapid increase in PSA levels.

Form: capsules, soft gelatin

ATC: L02BB04

Manufacturer: Adalvo Limited Lek Pharmaceuticals d.d. Pharmadox Healthcare Limited

The medicine is intended for adult men with prostate cancer. It is used in cases where the tumor does not respond to hormonal therapy or testosterone-lowering surgical treatment, when the cancer has spread to other parts of the body, or in men after surgery or radiation who experience a rapid increase in PSA levels and the cancer has not spread beyond the prostate.

Form: tablets, film-coated

ATC: L02BB04

Manufacturer: Clonmel Healthcare Ltd., PharOS Mt, STADA Arzneimittel AG, STADA Arzneimittel AG

The medicine is intended for adult men with prostate cancer. It is used when the disease does not respond to hormone therapy or testosterone-lowering treatments, when the cancer has spread to other parts of the body, or in men after surgery or radiation who experience a rapid increase in PSA levels but the cancer has not metastasized.

Form: tablets, film-coated

ATC: L02BB04

Manufacturer: Clonmel Healthcare Ltd., PharOS Mt, STADA Arzneimittel AG, STADA Arzneimittel AG

The medicine is intended for adult men with prostate cancer. It is used when the tumor does not respond to hormonal therapy or surgical treatment aimed at reducing testosterone levels, when the cancer has spread to other parts of the body, or in men after prostate removal or radiation therapy who experience a rapid increase in PSA levels.

Form: tablets, film-coated

ATC: L02BB04

Manufacturer: Clonmel Healthcare Limited PharOS Mt Ltd Pharos Pharmaceutical Oriented Services Ltd. STADA Arzneimittel AG

The medicine is intended for adult men with prostate cancer. It is used in cases where the tumor does not respond to hormonal or surgical therapy, when it has spread to other parts of the body, or in men after prostate removal or radiation therapy who experience a rapid increase in PSA levels.

Form: tablets, film-coated

ATC: L02BB04

Manufacturer: PharOS Mt Ltd

The medicine is intended for adult men with prostate cancer. It is used when the disease does not respond to hormonal or surgical therapy, when the cancer has spread to other parts of the body, or in men after surgery or radiation who experience a rapid increase in PSA levels.

Form: tablets, film-coated

ATC: L02BB04

Manufacturer: PharOS Mt Ltd